ADHD medicine recalled after wrong pills found in bottles
(Gray News) - Azurity Pharmaceuticals has recalled some of its ADHD and narcolepsy medicine after a different drug ended up in the pill bottles, the Food and Drug Administration reported.
The company says it issued the recall for Zenzedi after a Nebraska pharmacist noticed some of its bottles had an antihistamine medicine, carbinoxamine maleate, mixed in the package.
Zenzedi is a stimulant used for the treatment of ADHD and narcolepsy. Carbinoxamine is a sedative and has the opposite effect of a stimulant.
The recall warned that people who take the antihistamine instead of Zenzedi could experience drowsiness, which could put patients at risk of getting into an accident or injuring themselves.
The company says it has not received reports of anyone getting hurt because of the medicine mixup.
Information about the recalled medication is included below:
| Product | NDC No. | Lot No. | Expiration date | Ship Dates to Wholesalers |
|---|---|---|---|---|
| Zenzedi® (dextroamphetamine sulfate tablets, USP) 30 mg | 24338-856-03 | F230169A | June 2025 | 08/23/2023 – 11/29/2023 |
Zenzedi 30 mg tablets can be identified by light yellow hexagonal tablets with “30″ on one side and “MIA” on the other side. It is distributed in a white bottle with black writing and “30 mg” highlighted yellow.
The carbinoxamine maleate tablets that were erroneously put in Zenzedi bottles were described by the reporting pharmacist as white round tablets with imprints of “GL” on one side and “211″ on the other side.
The recalled product was distributed nationwide through pharmacies.
The FDA said consumers who have the recalled medicine should stop using it and return to the place of purchase.
Azurity is working with wholesalers and retailers to arrange for the return and replacement of the recalled product.
Those with concerns about the recall process should call Inmar Intelligence at 877-804-2069 during business hours Monday through Friday, 9 a.m. through 5 p.m. Eastern.
Those with medical or technical product information, or to report a technical product complaint or adverse event, call 800-461-7449 during business hours Monday through Friday, 9 a.m. through 5 p.m. Eastern.
Those who have experienced adverse effects from taking this product should contact their healthcare provider.
Copyright 2024 Gray Media Group, Inc. All rights reserved.